Skip to contentA
Acro Biomedical Co., Ltd.
A
ACBMAcro Biomedical Co., Ltd. Source filing unavailable
Q3 2019 · —
Revenue$0.00$0.00derivedno prior Q3 2018 on file Net Income-$75.16K-$75.16Kno prior Q3 2018 on file EPS Diluted$0.00$0.00no prior Q3 2018 on file Operating Income-$64,460—
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Acro Biomedical Co., Ltd. · CIK 1622996 · Engraved from SEC EDGAR
Operating Cash Flowderived$42,874—